CORCEPT THERAPEUTICS INC (CORT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300M 600M 900M Q3 '24: 628.6M Q4 '24: 675M Q1 '25: 685.4M Q2 '25: 716.1M Q3 '25: 741.2M Q4 '25: 761.4M Q1 '26: 769.1M Q2 '26: 830.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 150M 300M 450M Q1 '19: 253.1M Q2 '19: 262.9M Q3 '19: 279.8M Q4 '19: 301M Q1 '20: 328.8M Q2 '20: 345.2M Q3 '20: 350.3M Q4 '20: 348.3M Q1 '19 Q2 '19 Q3 '19 Q4 '19 Q1 '20 Q2 '20 Q3 '20 Q4 '20

Operating Income TTM

-50M 0 50M 100M 150M Q3 '24: 143.4M Q4 '24: 137M Q1 '25: 110.9M Q2 '25: 102M Q3 '25: 65.6M Q4 '25: 44.8M Q1 '26: -8.2M Q2 '26: 6.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

0 50M 100M 150M Q3 '24: 141.8M Q4 '24: 141.2M Q1 '25: 134M Q2 '25: 133.7M Q3 '25: 106.1M Q4 '25: 99.7M Q1 '26: 47.3M Q2 '26: 55.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 5M 10M 15M Q3 '24: 9.8M Q4 '24: 10.9M Q1 '25: 10.8M Q2 '25: 11.7M Q3 '25: 13.4M Q4 '25: 13M Q1 '26: 13.5M Q2 '26: 14.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

0 70M 140M 210M Q3 '24: 143.8M Q4 '24: 198.3M Q1 '25: 179.3M Q2 '25: 182.4M Q3 '25: 163.6M Q4 '25: 142M Q1 '26: 120.5M Q2 '26: 109.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

0 70M 140M 210M Q3 '24: 141.7M Q4 '24: 196.1M Q1 '25: 177M Q2 '25: 180.5M Q3 '25: 163.3M Q4 '25: 141.8M Q1 '26: 120.1M Q2 '26: 106.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '24: 109.9M Q2 '24: 111.2M Q3 '24: 113.7M Q1 '25: 119.8M Q2 '25: 120.5M Q3 '25: 119.4M Q1 '26: 104.4M Q2 '26: 118.4M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 0.50 1.00 1.50 Q3 '24: 1.26 Q4 '24: 1.23 Q1 '25: 1.15 Q2 '25: 1.12 Q3 '25: 0.87 Q4 '25: 0.82 Q1 '26: 0.35 Q2 '26: 0.42 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.